Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Drugs

Department of Health written question – answered on 14th March 2016.

Alert me about debates like this

Photo of Baroness Masham of Ilton Baroness Masham of Ilton Crossbench

To ask Her Majesty’s Government what is their assessment of the impact of the price of five per cent coal tar ointment on the NHS Drug Tariff for England and Wales on Clinical Commissioning Groups' decision to pay for that treatment.

Photo of Lord Prior of Brampton Lord Prior of Brampton The Parliamentary Under-Secretary of State, Department of Health

We have made no such assessment.

In primary care, the prescribing decision rests with the patient’s general practitioner. The cost of any medicine has to be balanced against the importance of meeting the individual treatment needs of patients and potential adverse consequences for patients and additional costs to the National Health Service if supply is interrupted, for example the re-emergence of symptoms or relapse of the condition on stopping treatment.

Clinical commissioning groups can issue prescribing advice taking into account the cost of medicine.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.